查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1756492

綜合多重診斷市場（按類型、最終用途、國家和地區）－2024 年至 2032 年產業分析、市場規模、市場佔有率及預測

Syndromic Multiplex Diagnostics Market, By Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 357 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年綜合多重診斷市場規模價值為 28.8976 億美元，2024 年至 2032 年的複合年成長率為 4.2%。

症候群多重診斷市場-市場動態

對快速準確診斷的需求不斷成長

對快速精準疾病識別日益成長的需求是綜合多重診斷市場的關鍵驅動力。傳統診斷方法通常耗時耗力，每次只能檢測一種病原體。相較之下，綜合診斷試劑盒的周轉時間較短，並且能夠從單一樣本中同時檢測多種病原體。這在傳染病疫情管理以及重症監護中尤其重要，因為及時診斷可以顯著影響患者的預後。全球對公共衛生防範和抗菌藥物管理的日益關注，進一步刺激了對此類先進診斷技術的需求。

綜合多重診斷市場－關鍵見解

根據我們的研究分析師，全球綜合多重診斷市場預計在 2024 年至 2032 年期間的複合年成長率約為 4.2%。

按 2024 年類型細分，呼吸類別佔據了市場主導地位。

根據最終用途，醫院部門在 2024 年創造了最多的收入。

按地區分類，2024年北美是收入最高的地區。

綜合多重診斷市場-細分分析：

全球綜合症多重診斷市場分為三類：類型、最終用戶和地區。

症候群多重診斷市場按類型細分為呼吸系統、胃腸道、中樞神經系統 (CNS) 和其他類型的症候群，其中包括複雜性泌尿道感染 (cUTI) 和性傳染病 (STD)。其中，呼吸系統疾病佔據了市場的主導地位。這種主導地位主要是由於呼吸道感染的高發生率，尤其是在季節性流感爆發和 COVID-19 等大流行期間。從單一樣本中快速識別多種呼吸道病原體的需求可提高臨床效率並支持有效的感染控制措施。此外，人們對早期診斷的認知不斷提高，醫院和照護端擴大採用症候群檢測組，這繼續增強了對呼吸道多重診斷解決方案的需求。

根據最終用途，症候群多重診斷市場細分為醫院、診斷實驗室和其他機構，包括診所、研究機構和即時診斷機構。其中，醫院佔據主導地位，因為其患者數量眾多、護理需求緊急且更容易獲得先進的診斷技術。醫院通常處理需要快速全面檢測的複雜病例，而症候群檢測組可以有效率地提供這些檢測。在急診和重症監護室整合多重診斷技術，可以及時做出決策並更好地管理患者，尤其是在傳染病爆發期間。此外，醫院還受益於內部實驗室和訓練有素的人員，這進一步支持了這些技術在關鍵症候群檢測應用中的廣泛應用。

綜合多重診斷市場—地理洞察

從地理分佈來看，症候群多重診斷市場分佈於北美、亞太、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美在症候群多重診斷市場佔據主導地位，這主要得益於其先進的醫療基礎設施、強大的研發能力以及對創新診斷技術的早期應用。尤其是美國，在分子診斷和旨在改善早期疾病檢測的公共衛生計劃方面投入巨資，引領該地區的發展。公眾對傳染病的普遍認知、政府資金投入以及完善的報銷框架進一步支撐了市場的成長。此外，呼吸道感染和慢性病的高發生率，以及強大的醫院和診斷實驗室網路，鞏固了北美在全球症候群多重診斷領域的領先地位。

歐洲是症候群多重診斷市場的另一個領先地區，這得益於對高效診斷解決方案日益成長的需求以及對先進醫療技術的有力監管支持。德國、英國和法國等國家處於領先地位，受益於現代化的醫療保健體系和大量的公共衛生投資。該地區對抗菌藥物管理和感染控制的重視加速了多重檢測在臨床環境中的應用。此外，老齡人口的成長以及呼吸道和胃腸道感染發病率的上升也進一步刺激了需求。歐洲致力於醫療保健創新，使其成為該市場的關鍵參與者。

綜合多重診斷市場-競爭格局：

綜合多重診斷市場由老牌診斷巨頭和創新新進入者共同塑造。雅培實驗室、賽默飛世爾科技、羅氏製藥、凱傑和生物梅里埃等領導企業憑藉全面的多重檢測組合和先進的分子平台佔據主導地位。這些公司在研發方面投入巨資，旨在提高檢測準確性、縮短週轉時間並擴大病原體覆蓋範圍。新進業者則專注於開發快速的即時診斷解決方案，以佔領利基市場。策略合作、併購進一步鞏固了市場地位。這種競爭環境推動持續創新，提升診斷能力，並為全球患者提供及時有效的醫療服務。

最新動態：

2025 年 3 月，雅培推出了新的快速多重呼吸道檢測面板，可在 30 分鐘內提供結果，從而增強臨床環境中的早期診斷和治療。

2024 年 1 月，賽默飛世爾科技收購了一家專門從事自動化 PCR 技術的分子診斷公司，擴大了其症候群檢測產品組合，從而擴大了其市場範圍。

目錄

第1章：綜合多重診斷市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 綜合多重診斷市場片段（按類型）
    • 綜合多重診斷市場片段（依最終用途）
    • 綜合多重診斷市場（按國家/地區）
    • 綜合多重診斷市場（按地區）
  • 競爭洞察

第3章：症候群多重診斷關鍵市場趨勢

  • 綜合多重診斷市場促進因素
    • 市場促進因素的影響分析
  • 綜合多重診斷市場限制
    • 市場限制的影響分析
  • 綜合多重診斷市場機遇
  • 症候群多重診斷市場未來趨勢

第4章：綜合多重診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：綜合多重診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：綜合多重診斷市場格局

  • 2023年綜合多重診斷市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：綜合多重診斷市場－依類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 呼吸系統
    • 胃腸道
    • 中樞神經系統
    • 其他類型的症候群（cUTI 和 STD）

第 8 章：綜合多重診斷市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 診斷實驗室
    • 其他

第9章：綜合多重診斷市場－按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美綜合多重診斷主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測，按最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲綜合多重診斷主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測，按最終用途
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區綜合多重診斷主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（按類型）
    • 亞太市場規模及預測（依最終用途）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲綜合多重診斷主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲綜合多重診斷主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模和預測（按類型）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 10 章：關鍵供應商分析-綜合多重診斷產業

  • 競爭儀錶板
  • 公司簡介
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd
    • Qiagen
    • bioMerieux
    • DiaSorin SpA (Luminex Corporation)
    • Hologic, Inc.
    • Becton, Dickinson and Company (BD)
    • Applied BioCode
    • QIAGEN
    • Curetis GmbH
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5248

REPORT HIGHLIGHT

Syndromic Multiplex Diagnostics Market size was valued at USD 2,889.76 Million in 2024, expanding at a CAGR of 4.2% from 2024 to 2032.

Syndromic multiplex diagnostics is an advanced diagnostic approach that simultaneously tests for multiple pathogens or biomarkers associated with a specific syndrome using a single test panel. This method integrates molecular techniques, such as PCR, to rapidly identify the causative agents of illnesses with overlapping symptoms like respiratory, gastrointestinal, or neurological infections. By targeting a broad spectrum of pathogens in one test, it enhances diagnostic accuracy, reduces time to treatment, and supports more effective clinical decision-making. This approach is particularly useful in settings where rapid identification of the illness source is critical, such as hospitals, emergency care, and outbreak scenarios.

Syndromic Multiplex Diagnostics Market- Market Dynamics

Rising Demand for Rapid and Accurate Diagnostics

The growing need for fast and precise disease identification is a key driver for the syndromic multiplex diagnostics market. Traditional diagnostic methods are often time-consuming and limited to detecting one pathogen at a time. In contrast, syndromic panels offer quicker turnaround times and the ability to detect multiple pathogens simultaneously from a single sample. This is especially valuable in managing infectious disease outbreaks and in critical care settings, where timely diagnosis can significantly impact patient outcomes. Increased global focus on public health preparedness and antimicrobial stewardship further fuels the demand for such advanced diagnostics.

Syndromic Multiplex Diagnostics Market- Key Insights

According to our research analyst, the global Syndromic Multiplex Diagnostics Market is expected to develop at a CAGR of approximately 4.2% between 2024-2032.

Segmented by Type in 2024, the Respiratory category dominated the market.

Based on End Use, the Hospitals segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Syndromic Multiplex Diagnostics Market- Segmentation Analysis:

The global Syndromic Multiplex Diagnostics Market is divided into Three categories: Type, End-user, and Region.

The syndromic multiplex diagnostics market is segmented by type into Respiratory, Gastrointestinal, Central Nervous System (CNS), and Other Types of Syndromes, which include complicated urinary tract infections (cUTIs) and sexually transmitted diseases (STDs). Among these, the Respiratory segment holds the dominant share of the market. This dominance is primarily driven by the high prevalence of respiratory infections, especially during seasonal flu outbreaks and pandemics such as COVID-19. The need for rapid identification of multiple respiratory pathogens from a single sample enhances clinical efficiency and supports effective infection control measures. Moreover, growing awareness of early diagnosis and increasing adoption of syndromic panels in hospitals and point-of-care settings continue to bolster the demand for respiratory multiplex diagnostic solutions.

By end use, the syndromic multiplex diagnostics market is segmented into Hospitals, Diagnostic Laboratories, and Others, which include clinics, research institutes, and point-of-care settings. Among these, Hospitals represent the dominant segment due to their high patient volume, urgent care requirements, and greater access to advanced diagnostic technologies. Hospitals often deal with complex cases requiring rapid and comprehensive testing, which syndromic panels efficiently provide. The integration of multiplex diagnostics in emergency departments and intensive care units enables timely decision-making and better patient management, especially during infectious disease outbreaks. Additionally, hospitals benefit from in-house laboratories and trained personnel, further supporting the widespread adoption of these technologies for critical syndromic testing applications.

Syndromic Multiplex Diagnostics Market- Geographical Insights

Geographically, the Syndromic Multiplex Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the syndromic multiplex diagnostics market, primarily due to its advanced healthcare infrastructure, strong R&D capabilities, and early adoption of innovative diagnostic technologies. The United States, in particular, leads the region with significant investments in molecular diagnostics and public health initiatives aimed at improving early disease detection. Widespread awareness of infectious diseases, government funding, and well-established reimbursement frameworks further support market growth. Additionally, the high prevalence of respiratory infections and chronic conditions, along with a robust network of hospitals and diagnostic laboratories, reinforces North America's leading role in the global syndromic multiplex diagnostics landscape.

Europe is another leading region in the syndromic multiplex diagnostics market, driven by increasing demand for efficient diagnostic solutions and strong regulatory support for advanced medical technologies. Countries such as Germany, the United Kingdom, and France are at the forefront, benefiting from modern healthcare systems and substantial public health investments. The region's focus on antimicrobial stewardship and infection control has accelerated the adoption of multiplex panels in clinical settings. Moreover, the growing elderly population and rising incidence of respiratory and gastrointestinal infections have further contributed to demand. Europe's commitment to healthcare innovation positions it as a key player in this market.

Syndromic Multiplex Diagnostics Market- Competitive Landscape:

The syndromic multiplex diagnostics market is shaped by established diagnostics giants and innovative newcomers. Leading players such as Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Qiagen, and bioMerieux dominate with comprehensive multiplex panels and advanced molecular platforms. These companies invest heavily in R&D to enhance test accuracy, reduce turnaround times, and expand pathogen coverage. New entrants focus on developing rapid, point-of-care solutions to capture niche markets. Strategic collaborations, mergers, and acquisitions further strengthen market positions. This competitive environment drives continuous innovation, improving diagnostic capabilities and supporting timely, effective patient care worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid multiplex respiratory panel that delivers results in under 30 minutes, enhancing early diagnosis and treatment in clinical settings.

In January 2024, Thermo Fisher expanded its syndromic testing portfolio by acquiring a molecular diagnostics company specializing in automated PCR technologies, boosting its market reach.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • Biomerieux
  • Diasorin S.P.A (Luminex Corporation)
  • Hologic, Inc.
  • Becton, Dickinson And Company (Bd)
  • Applied Biocode
  • Qiagen
  • Curetis Gmbh
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Other Types Of Syndromes (Cuti And Stds)

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Syndromic Multiplex Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Syndromic Multiplex Diagnostics Market Snippet by Type
    • 2.1.2. Syndromic Multiplex Diagnostics Market Snippet by End Use
    • 2.1.3. Syndromic Multiplex Diagnostics Market Snippet by Country
    • 2.1.4. Syndromic Multiplex Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Syndromic Multiplex Diagnostics Key Market Trends

  • 3.1. Syndromic Multiplex Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Syndromic Multiplex Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Syndromic Multiplex Diagnostics Market Opportunities
  • 3.4. Syndromic Multiplex Diagnostics Market Future Trends

4. Syndromic Multiplex Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Syndromic Multiplex Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Syndromic Multiplex Diagnostics Market Landscape

  • 6.1. Syndromic Multiplex Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Syndromic Multiplex Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Respiratory
    • 7.1.3. Gastrointestinal
    • 7.1.4. Central Nervous System
    • 7.1.5. Other Types of Syndromes (cUTI and STDs)

8. Syndromic Multiplex Diagnostics Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Diagnostic Laboratories
    • 8.1.4. Others

9. Syndromic Multiplex Diagnostics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Syndromic Multiplex Diagnostics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Syndromic Multiplex Diagnostics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Syndromic Multiplex Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Syndromic Multiplex Diagnostics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Syndromic Multiplex Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Syndromic Multiplex Diagnostics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Thermo Fisher Scientific, Inc.
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. Qiagen
    • 10.2.5. bioMerieux
    • 10.2.6. DiaSorin S.p.A (Luminex Corporation)
    • 10.2.7. Hologic, Inc.
    • 10.2.8. Becton, Dickinson and Company (BD)
    • 10.2.9. Applied BioCode
    • 10.2.10. QIAGEN
    • 10.2.11. Curetis GmbH
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us